Skip to content
Wise Vision Dutch

The Zimbabwean Government Rejects ‘Lopsided’ US Health Aid Deal Due to Information Concerns

Health aid illustration
The proposed American financial assistance was intended for initiatives for treating and preventing HIV/Aids, TB, and malarial diseases.

Zimbabwe has rejected a substantial American health deal valued at 367 million US dollars (272 million pounds) over five years due to Washington's demand for confidential data.

This move was revealed following a government memo from December was leaked, which showed President Emmerson Mnangagwa believed the deal was "unbalanced".

An official spokesman has since stated that the United States was requesting health data for research and profit while was unwilling to guarantee the benefits from future treatments.

"We must now begin the difficult and regrettable process of winding down our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.

Her embassy said the United States had provided more than $1.9bn in health funding to Zimbabwe during the past two decades.

A physicians' group in Zimbabwe has called for continued dialogue to find a deal agreeable to both sides so the nation's vital HIV treatment initiative can continue.

Broader Context

This development follows a comparable situation in neighbouring Kenya, where a high court blocked a similar health funding agreement following concerns were filed about the safety of citizens' medical information.

After returning to the presidency last year, US President Donald Trump has drastically cut overseas assistance and shut down the key foreign aid agency.

The agency had managed assistance for the American government, but Trump argued its spending was "inefficient" and his administration was pursuing direct bilateral agreements to boost openness and responsibility.

According to reports, 16 African countries have so far signed similar health pacts, constituting more than $18.3bn of fresh investment.

Specifics of the Rejected Agreement

The funds for Zimbabwe was intended to gone towards "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".

"We believe this cooperation could have provided significant benefits for Zimbabwean communities, especially the 1.2 million currently receiving HIV treatment through US-supported initiatives," the Ambassador said.

However, government spokesperson Nick Mangwana maintained the arrangement was "asymmetrical".

"The proposal required Zimbabwe to provide its biological resources and data over an extended period, without any corresponding promise of access to any scientific breakthroughs – like new medicines or tests – that could be developed from that provided information," Mangwana explained.

"Effectively, our country would supply the basic resources for medical research without any certainty that the end products would be accessible to our people should a new health crisis emerge."

National Interest and Global Health

He also said that the American exit from the World Health Organization (WHO) and its push of bilateral deals were undermining frameworks already established via the global organization.

Mangwana gave as an example its Pandemic Benefit-Sharing scheme created to deal with potential pandemics.

"This mechanism is designed to ensure that when a country contributes its samples, the benefits – such as vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the funds to develop them."

These objections over the US deal "should not be misconstrued as opposition to America," he added.

"We encourage ongoing dialogue with our US partners on how subsequent collaboration might be designed in a manner that honours the sovereignty and dignity of both nations."

Health Experts Response

The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it acknowledged the official position, but urged that negotiations need to persist considering much of the country's Aids initiatives relied on external financing.

"If specific concerns arise, including those involving data governance or agreement terms, these can often be addressed through detailed discussion and mutually agreed protections," it said.

The halted deal emphasises the complex tensions between receiving vital foreign assistance and protecting a country's data in an increasingly interconnected world.

About the author

Mary Lutz

Elena Vries is een ervaren levenscoach en schrijver, gespecialiseerd in mindfulness en persoonlijke ontwikkeling.

Wise Vision Dutch

Type to search articles.